Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
PIQRAY Drug Insight and Market Forecast – 2032
... of the PIQRAY for ER+ve HER2-ve Breast Cancer in the United States for the study period 2019–2032 is provided in this report along with a detailed description of the PIQRAY for ER+ve HER2-ve Breast Cancer. ... Read More
-
VERZENIO Drug Insight and Market Forecast – 2032
... of the VERZENIO for ER+ve HER2-ve Breast Cancer in the United States for the study period 2019–2032 is provided in this report along with a detailed description of the VERZENIO for ER+ve HER2-ve Breast Cancer. ... Read More
-
Mirikizumab Emerging Drug Insight and Market Forecast − 2032
... picture of the mirikizumab for ulcerative colitis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in ... Read More
-
KEVZARA Drug Insight and Market Forecast – 2032
... Rheumatoid Arthritis in the 7MM, i.e., United States, EU4 (Germany, France, Italy, Spain), and the United Kingdom, and Japan for the study period 2019–2032 is provided in this report along with a detailed description of ... Read More
-
Remestemcel-L Emerging Drug Insight and Market Forecast − 2032
... picture of the remestemcel-L for ulcerative colitis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in ... Read More
-
CS1 Emerging Drug Insight and Market Forecast – 2032
... the CS1 for Pulmonary Arterial Hypertension in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with ... Read More
-
Birtamimab Emerging Drug Insight and Market Forecast – 2032
... Birtamimab for AL Amyloidosis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
KISQALI Drug Insight and Market Forecast – 2032
... of the KISQALI for ER+ve HER2-ve Breast Cancer in the United States for the study period 2019–2032 is provided in this report along with a detailed description of the KISQALI for ER+ve HER2-ve Breast Cancer. ... Read More
-
Lerociclib Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the Lerociclib for ER+ve HER2-ve Breast Cancer in the United States for the study period 2019–2032 is provided in this report along with a detailed description of the Lerociclib for ER+ve HER2-ve ... Read More
-
FASLODEX Drug Insight and Market Forecast – 2032
... of the FASLODEX for ER+ve HER2-ve Breast Cancer in the United States for the study period 2019–2032 is provided in this report along with a detailed description of the FASLODEX for ER+ve HER2-ve Breast Cancer. ... Read More
-
2023 Global Forecast for Non-narcotic internal analgesics and anti-pyrectics, anti-arthritics and anti-inflammatory (2023-2028 Outlook)-Manufacturing & Markets Report
... over 40 countries. Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2028. Product shipments include the total ... Read More
-
2023 Global Forecast for Other internal analgesics and antipyretics, including effervescent types and suppositories (2023-2028 Outlook)-Manufacturing & Markets Report
... market for over 40 countries. Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2028. Product shipments include ... Read More
-
2023 Global Forecast for Narcotic internal analgesics and antipyretics, opium and derivatives (2023-2028 Outlook)-Manufacturing & Markets Report
... over 40 countries. Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2028. Product shipments include the total ... Read More
-
2023 Global Forecast for Prescription sedatives and hypnotics, non-barbiturates (2023-2028 Outlook)-Manufacturing & Markets Report
... Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2028. Product shipments include the total value of all ... Read More
-
2023 Global Forecast for Cough preparations and expectorants, narcotic and non-narcotic, prescription (2023-2028 Outlook)-Manufacturing & Markets Report
... over 40 countries. Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2028. Product shipments include the total ... Read More
-
2023 Global Forecast for Narcotic internal analgesics and antipyretics, synthetic narcotics (2023-2028 Outlook)-Manufacturing & Markets Report
... 40 countries. Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2028. Product shipments include the total value ... Read More
-
2023 Global Forecast for Psychotherapeutic agents, tranquilizers, phenothiazine derivatives (2023-2028 Outlook)-Manufacturing & Markets Report
... Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2028. Product shipments include the total value of all ... Read More
-
2023 Global Forecast for Non-narcotic internal analgesics and anti-pyrectics, acetaminophen and combinations (2023-2028 Outlook)-Manufacturing & Markets Report
... over 40 countries. Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2028. Product shipments include the total ... Read More
-
Alzheimer Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
... Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Alzheimer pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in ... Read More
-
China COPD & Asthma Market 2022-2028
... setting and Clinics Center) Forecast Period (2021-2028) The China Chronic obstructive pulmonary disease (COPD) & asthma market was valued at around $3.5 billion in 2021 and is estimated to reach nearly $4.7 billion in 2028, ... Read More
-
Global Helicobacter Pylori Diagnostics Market - 2022-2029
... a CAGR of 10.86% during the forecast period (2022-2029). Helicobacter pylori is a corkscrew-based bacteria identified in 1982 as a significant cause of chronic gastritis and stomach ulcers. These conditions are formerly believed to form ... Read More
-
Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Uveitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Uveitis. Report includes ... Read More
-
Acne Vulgaris Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Acne Vulgaris Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Global Sleep Aids Market - 2022-2029
... of 4.8% during the forecast period (2022-2029). Sleep disorders are conditions that interrupt or weaken sleeping patterns, resulting in daytime sleepiness and other sleep aid symptoms. Inadequate sleep can cause problems in college, as well ... Read More
-
Restless Legs Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Restless Legs Syndrome Clinical trials scenario. This report provides top line data relating to the ... Read More
Research Assistance
